KATIE CONKLIN: Open Payments
NPI 1235546607 · PORTLAND, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,134 in 53 payments from 12 companies in 2025. Trend: 2023 $1,124 · 2024 $1,607 · 2025 $1,134
Food & beverage: $1,026Education: $108
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $512 |
| Janssen Biotech, Inc. | 18 | $217 |
| Regeneron Healthcare Solutions, Inc. | 2 | $130 |
| Novartis Pharmaceuticals Corporation | 2 | $56 |
| UCB, Inc. | 2 | $40 |
| Arcutis Biotherapeutics, Inc. | 2 | $39 |
| Organon LLC | 1 | $34 |
| LEO Pharma Inc. | 1 | $25 |
| Galderma Laboratories, L.P. | 1 | $25 |
| PFIZER INC. | 1 | $20 |
Products named: SKYRIZI, TREMFYA, DUPIXENT, RINVOQ, Bimzelx, Zoryve, COSENTYX, VTAMA.
Industry payments across OR — which companies pay providers there.
